Table 1 from AZD8701, an Antisense Oligonucleotide Targeting FOXP3 mRNA, as Monotherapy and in Combination with Durvalumab: A Phase I Trial in Patients with Advanced Solid Tumors
收藏Figshare2025-04-14 更新2026-04-28 收录
下载链接：
https://figshare.com/articles/dataset/Table_1_from_AZD8701_an_Antisense_Oligonucleotide_Targeting_FOXP3_mRNA_as_Monotherapy_and_in_Combination_with_Durvalumab_A_Phase_I_Trial_in_Patients_with_Advanced_Solid_Tumors/29053069
下载链接
链接失效反馈官方服务：
资源简介：
Baseline patient and disease characteristics (safety population).
创建时间：
2025-04-14
